TNF and neoplasm: Administration of SL7207 is accompanied by a change in the immune phenotype of the tumor‐infiltrating cells toward pro‐inflammatory, with expression of the TH1 cytokines IFN‐γ, TNF‐α, and IL‐12 significantly increased.